These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 4091785)
21. Infarct size-reducing effect of nicorandil is mediated by the KATP channel but not by its nitrate-like properties in dogs. Mizumura T; Nithipatikom K; Gross GJ Cardiovasc Res; 1996 Aug; 32(2):274-85. PubMed ID: 8796114 [TBL] [Abstract][Full Text] [Related]
22. Infarct size reduction with the nucleoside transport inhibitor R-75231 in swine. Martin BJ; Lasley RD; Mentzer RM Am J Physiol; 1997 Apr; 272(4 Pt 2):H1857-65. PubMed ID: 9139972 [TBL] [Abstract][Full Text] [Related]
23. Oral pretreatment with mioflazine completely changes the pattern and remarkably prolongs the accumulation of nucleosides in ischemic and reperfused myocardium. Van Belle H; Xhonneux R; Flameng W; Wynants J Basic Res Cardiol; 1986; 81(4):407-16. PubMed ID: 3778420 [TBL] [Abstract][Full Text] [Related]
24. Coronary cyclic flow variations "precondition" ischemic myocardium. Ovize M; Kloner RA; Hale SL; Przyklenk K Circulation; 1992 Feb; 85(2):779-89. PubMed ID: 1735170 [TBL] [Abstract][Full Text] [Related]
25. Reduction in myocardial infarct size by basic fibroblast growth factor following coronary occlusion in a canine model. Horrigan MC; Malycky JL; Ellis SG; Topol EJ; Nicolini FA Int J Cardiol; 1999 Apr; 68 Suppl 1():S85-91. PubMed ID: 10328616 [TBL] [Abstract][Full Text] [Related]
26. Effect of verapamil on postischemic "stunned" myocardium: importance of the timing of treatment. Przyklenk K; Kloner RA J Am Coll Cardiol; 1988 Mar; 11(3):614-23. PubMed ID: 3278036 [TBL] [Abstract][Full Text] [Related]
27. Limitation of Infarct Size and No-Reflow by Intracoronary Adenosine Depends Critically on Dose and Duration. Yetgin T; Uitterdijk A; Te Lintel Hekkert M; Merkus D; Krabbendam-Peters I; van Beusekom HMM; Falotico R; Serruys PW; Manintveld OC; van Geuns RM; Zijlstra F; Duncker DJ JACC Cardiovasc Interv; 2015 Dec; 8(15):1990-1999. PubMed ID: 26738671 [TBL] [Abstract][Full Text] [Related]
28. Adenosine A1 receptors, KATP channels, and ischemic preconditioning in dogs. Auchampach JA; Gross GJ Am J Physiol; 1993 May; 264(5 Pt 2):H1327-36. PubMed ID: 8498546 [TBL] [Abstract][Full Text] [Related]
29. Preservation of high-energy phosphates by verapamil in reperfused myocardium. Lange R; Ingwall J; Hale SL; Alker KJ; Braunwald E; Kloner RA Circulation; 1984 Oct; 70(4):734-41. PubMed ID: 6478571 [TBL] [Abstract][Full Text] [Related]
30. Myocardial protection with verapamil during ischaemia and reperfusion: dissociation between myocardial salvage and the degree of ATP depletion during ischaemia. Wolfe CL; Donnelly TJ; Sievers R; Parmley WW Cardiovasc Res; 1991 Feb; 25(2):101-9. PubMed ID: 1742760 [TBL] [Abstract][Full Text] [Related]
31. Sevoflurane reduces myocardial infarct size and decreases the time threshold for ischemic preconditioning in dogs. Toller WG; Kersten JR; Pagel PS; Hettrick DA; Warltier DC Anesthesiology; 1999 Nov; 91(5):1437-46. PubMed ID: 10551596 [TBL] [Abstract][Full Text] [Related]
33. Alpha-human atrial natriuretic peptide, carperitide, reduces infarct size but not arrhythmias after coronary occlusion/reperfusion in dogs. Takagi G; Kiuchi K; Endo T; Yamamoto T; Sato N; Nejima J; Takano T J Cardiovasc Pharmacol; 2000 Jul; 36(1):22-30. PubMed ID: 10892656 [TBL] [Abstract][Full Text] [Related]
34. Limitation of myocardial infarct size by superoxide dismutase as an adjunct to reperfusion after different durations of coronary occlusion in the pig. Näslund U; Häggmark S; Johansson G; Marklund SL; Reiz S Circ Res; 1990 May; 66(5):1294-301. PubMed ID: 2335028 [TBL] [Abstract][Full Text] [Related]
35. Reduction in infarct size by the prostacyclin analogue iloprost (ZK 36374) after experimental coronary artery occlusion-reperfusion. Chiariello M; Golino P; Cappelli-Bigazzi M; Ambrosio G; Tritto I; Salvatore M Am Heart J; 1988 Mar; 115(3):499-504. PubMed ID: 2449815 [TBL] [Abstract][Full Text] [Related]
36. Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs. Gross GJ; Auchampach JA Circ Res; 1992 Feb; 70(2):223-33. PubMed ID: 1310443 [TBL] [Abstract][Full Text] [Related]
37. The relationships of high energy phosphates, tissue pH, and regional blood flow to diastolic distensibility in the ischemic dog myocardium. Momomura S; Ingwall JS; Parker JA; Sahagian P; Ferguson JJ; Grossman W Circ Res; 1985 Dec; 57(6):822-35. PubMed ID: 4064257 [TBL] [Abstract][Full Text] [Related]
38. Verapamil in two reperfusion models of myocardial infarction. Temporary protection of severely ischemic myocardium without limitation of ultimate infarct size. Reimer KA; Jennings RB Lab Invest; 1984 Dec; 51(6):655-66. PubMed ID: 6503220 [TBL] [Abstract][Full Text] [Related]
39. Cloricromene reduces infarct size and alters postischaemic blood flow defects in dog myocardium. Groban L; Zvara DA; Deal DD; Vernon JC; Flye CW; Ma XL; Vinten-Johansen J Clin Exp Pharmacol Physiol; 1998 Jun; 25(6):417-23. PubMed ID: 9673816 [TBL] [Abstract][Full Text] [Related]
40. Effects of ischemic and adenosine preconditioning on interstitial fluid adenosine and myocardial infarct size. Lasley RD; Konyn PJ; Hegge JO; Mentzer RM Am J Physiol; 1995 Oct; 269(4 Pt 2):H1460-6. PubMed ID: 7485581 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]